Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 10Breast Diseases 2Sexuality 1Polycystic Ovary Syndrome 1Neoplasms, Hormone-Dependent 1Luminal B/HER2-negative Breast Cancer 1Infertility 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Advanced Breast Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Advanced Breast Cancer 1

Interventions

pyrotinib 4Letrozole 4Trastuzumab 3Docetaxel 3Anastrozole 3exemestane 2Epirubicin 2Drug Evaluation 2Doxorubicin 2Cyclophosphamide 2Capecitabine 2Aromatase Inhibitors 2palbociclib 1abemaciclib 1Vinorelbine 1Tomography, X-Ray Computed 1Tamoxifen 1Surgimend 1Sodium Chloride 1Paclitaxel 1Mammaplasty 1Liquid Biopsy 1Lead 1Lapatinib 1Goserelin 1Fulvestrant 1Drug Therapy 1Cryotherapy 1Carboplatin 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Diseases × Aromatase Inhibitors × Clear all
NCT04088110 2019-09-12

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Fuzhou General Hospital

Phase 2 Unknown
77 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT03910712 2019-04-10

Pyrotinib

Peking Union Medical College Hospital

Phase 2 Unknown
250 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡